CK Life Sciences International (Holdings), Inc. (HK:0775)
:0775
Want to see HK:0775 full AI Analyst Report?
Total Valuation
CK Life Sciences International (Holdings), Inc. has a market cap or net worth of HK$6.92B. The enterprise value is HK$12.94B.
Market CapHK$6.92B
Enterprise ValueHK$12.94B
Share Statistics
CK Life Sciences International (Holdings), Inc. has 9,611,072,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,611,072,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CK Life Sciences International (Holdings), Inc.’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -1.25%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)-1.25%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee2.66M
Profits Per Employee-91.89K
Employee Count2,033
Asset Turnover0.46
Inventory Turnover3.76
Valuation Ratios
The current PE Ratio of CK Life Sciences International (Holdings), Inc. is ―. CK Life Sciences International (Holdings), Inc.’s PEG ratio is -0.89.
PE Ratio―
PS Ratio1.46
PB Ratio2.09
Price to Fair Value2.09
Price to FCF-28.37
Price to Operating Cash Flow-213.58
PEG Ratio-0.89
Income Statement
In the last 12 months, CK Life Sciences International (Holdings), Inc. had revenue of 5.41B and earned -188.45M in profits. Earnings per share was -0.02.
Revenue5.41B
Gross Profit785.38M
Operating Income-135.28M
Pretax Income-18.01M
Net Income-188.45M
EBITDA-49.42M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -32.77M and capital expenditures -244.98M, giving a free cash flow of -277.76M billion.
Operating Cash Flow-32.77M
Free Cash Flow-277.76M
Free Cash Flow per Share-0.03
Dividends & Yields
CK Life Sciences International (Holdings), Inc. pays an annual dividend of HK$0.008, resulting in a dividend yield of ―
Dividend Per ShareHK$0.008
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.81
52-Week Price Change-22.58%
50-Day Moving Average0.78
200-Day Moving Average0.87
Relative Strength Index (RSI)46.78
Average Volume (3m)7.56M
Important Dates
CK Life Sciences International (Holdings), Inc. upcoming earnings date is Aug 11, 2026, TBA (Confirmed).
Last Earnings DateMar 17, 2026
Next Earnings DateAug 11, 2026
Ex-Dividend Date―
Financial Position
CK Life Sciences International (Holdings), Inc. as a current ratio of 0.87, with Debt / Equity ratio of 175.18%
Current Ratio0.87
Quick Ratio0.51
Debt to Market Cap0.78
Net Debt to EBITDA-121.79
Interest Coverage Ratio-0.51
Taxes
In the past 12 months, CK Life Sciences International (Holdings), Inc. has paid 170.44M in taxes.
Income Tax170.44M
Effective Tax Rate-9.46
Enterprise Valuation
CK Life Sciences International (Holdings), Inc. EV to EBITDA ratio is -281.27, with an EV/FCF ratio of -50.04.
EV to Sales2.57
EV to EBITDA-281.27
EV to Free Cash Flow-50.04
EV to Operating Cash Flow-424.12
Balance Sheet
CK Life Sciences International (Holdings), Inc. has HK$603.07M in cash and marketable securities with HK$6.62B in debt, giving a net cash position of -HK$6.02B billion.
Cash & Marketable SecuritiesHK$603.07M
Total DebtHK$6.62B
Net Cash-HK$6.02B
Net Cash Per Share-HK$0.63
Tangible Book Value Per ShareHK$0.05
Margins
Gross margin is 21.44%, with operating margin of -2.50%, and net profit margin of -3.48%.
Gross Margin21.44%
Operating Margin-2.50%
Pretax Margin-0.33%
Net Profit Margin-3.48%
EBITDA Margin-0.91%
EBIT Margin-2.50%
Analyst Forecast
The average price target for CK Life Sciences International (Holdings), Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-2.04%
EPS Growth Forecast-46.97%